InsidersTradesSigma
Track the Novonesis (Novozymes A/S) share price and the full insider trade history of the company, a listed equity based in Denmark. Shares are listed on the DK market, under the oversight of Finanstilsynet DK. Operating in the Chemicals sector, Novonesis (Novozymes A/S) has published 292 insider filings. Market capitalisation: €210.1bn. The latest transaction was filed on 25 August 2026 (Other). Every trade is free.
292
Insider Decl.
n/a
Thresholds
€1bn
95 ops.
Buy Volume
€231m
35 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Novonesis (Novozymes A/S) Buy (bullish), based on 15 analysts. Average price target: DKK 480.93.
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,165 of 29,064 companies
50.9
score / 100
Value37
Quality65
FCF yld0.3%
Earn yld0.3%
EV/EBITDA·
ROE5.8%
Gross mgn54%
Net mgn14%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 August 2026
Declarations292 total
12,500 shares@ DKK 446.1231ShareXCSEISIN DK0060336014DK:1460010
2,500 shares@ DKK 393.69160.6% of flowShareOMX CopenhagenISIN DK0060336014DK:1440144
400 shares@ DKK 371.800.1% of flowShareNasdaq CopenhagenISIN DK0060336014DK:1429237
4 shares@ DKK 3.000.0% of flowShareXCSEISIN DK0060336014DK:1428126
725 shares@ DKK 347.400.2% of flowShareNasdaqISIN DK0060336014DK:1425698
1,500 shares@ DKK 368.100.3% of flowShareUBS SIISIN DK0060336014DK:1423171
2,700 shares@ DKK 371.98020.6% of flowShareOMX CopenhagenISIN DK0060336014DK:1422930
18,337 shares@ DKK 368.504.2% of flowShareOutside a trading venueISIN DK0060336014DK:1422788
2,500 shares@ DKK 397.07160.6% of flowShareNasdaqISIN DK0060336014DK:1402016
380 shares@ DKK 418.100.1% of flowShareNasdaq XCSEISIN DK0060336014DK:1399510
ShareOutside a trading venueISIN DK0060336014DK:1398579
48,610 shares@ DKK 286.09068.6% of flowShareOutside a trading venueISIN DK0060336014DK:1386700
2,000 shares@ DKK 396.22920.5% of flowShare- Turquoise EuropeISIN DK0060336014DK:1385800
2,000 shares@ DKK 396.22920.5% of flowShare- Turquoise EuropeISIN DK0060336014DK:1385794
716 shares@ DKK 390.000.2% of flowShareNasdaq CopenhagenISIN DK0060336014DK:1384879
3,000 shares@ DKK 398.490.7% of flowShareOMX CopenhagenISIN DK0060336014DK:1384811
34,407 shares@ DKK 350.807.5% of flowShareOutside a trading venueISIN DK0060336014DK:1368228
19,934 shares@ DKK 249.403.1% of flowShareOutside a trading venueISIN DK0060336014DK:1362576
1,000 shares@ DKK 402.41460.2% of flowShareXCSEISIN DK0060336014DK:1351471
26,550 shares@ DKK 249.404.1% of flowShareOutside a trading venueISIN DK0060336014DK:1347415
1,000 shares@ DKK 439.500.3% of flowShareXCSEISIN DK0060336014DK:1347062
1,620 shares@ DKK 425.300.4% of flowShareXCSEISIN DK0060336014DK:1346494
12,120 shares@ DKK 428.103.2% of flowShareOutside a trading venueISIN DK0060336014DK:1345683
ShareOutside a trading venueISIN DK0060336014DK:1335997
Share- Cboe Europe Equities - European Equities (Nl)ISIN DK0060336014DK:1328947
25 of 292 declarations
Acerca de Novonesis (Novozymes A/S)
Novonesis es una subsidiaria de Novozymes A/S, enfocada en el desarrollo de soluciones enzimáticas y biológicas. La empresa enfatiza la innovación sostenible para varios sectores, incluyendo la agricultura y la alimentación.